Kelechi Agbi, PharmD, BCGP, RPh discusses his experience and the value he found collaborating with PCCA Science.

PCCA Clinical Compounding Pharmacist Deborah Clark outlines the prevalence of persistent loss of smell in COVID-19 patients as well as three potential treatment options that have been discussed in medical literature.

Flavoring expert Fabiana Banov lists the most popular flavors for oral compounds along with the sweeteners and other ingredients you need to start making custom medications more palatable for your patients.

As the compounding industry continues to grow, expectations for pharmacy compounders grow as well. Vigorous research and transparent scientific data are paramount to proving and promoting the impact of compounded medicines on patients.

Members of PCCA's Formulations team provide definitions and differentiating factors regarding the various alcohols used in Pharmacy Compounding.

PCCA's Director of Formulation Development explains how to create a eutectic mixture and how to choose the right form of lidocaine to use in topical compounded medications.

One of PCCA's clinical compounding pharmacists highlights the most critical stability factors listed in USP Chapter 1191 as well as the most common signs of instability in compounded medications.

Two of our formulation experts provide information about the most popular troche molds, rapid dissolve tablet molds and suppository molds that PCCA offers to help compounding pharmacies choose the best one for each patient.

Two pharmacists explain how compounded medication may be able to help patients experiencing various addictions and mental illness.

Mike Johnston of the National Pharmacy Technician Association (NPTA) shares his thoughts on how the profession has progressed over the last 25 years. He also offers advice to technicians on how to advance their careers.